Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Academic Article uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • Coronary Artery Disease
  • Lipids
  • Lovastatin

abstract

  • Persons with average TC and LDL-C levels and below-average HDL-C may obtain significant clinical benefit from primary-prevention lipid modification. On-treatment apoB, especially when combined with apoAI to form the apoB/AI ratio, may be a more accurate predictor than LDL-C of risk for first AMCE.

publication date

  • February 8, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10662743

Additional Document Info

start page

  • 477

end page

  • 84

volume

  • 101

number

  • 5